Franck Morschhauser Selected Research

Doxorubicin (Adriamycin)

2/2024	Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.
11/2023	Phase 2 LYSA study of prednisone, vinblastine, doxorubicin, bendamustine for untreated older Hodgkin lymphoma patients.
1/2023	Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis.
10/2022	Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2.
1/2022	Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study.
1/2022	Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.
10/2021	High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B.
1/2021	A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma.
1/2019	PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.
1/2019	Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b-2 study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Franck Morschhauser Research Topics

Disease

50	Lymphoma (Lymphomas) 02/2024 - 08/2003
46	Neoplasms (Cancer) 04/2024 - 08/2003
37	Hodgkin Disease (Hodgkin's Disease) 11/2023 - 01/2003
36	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 07/2007
34	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023 - 02/2008
32	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024 - 08/2010
26	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 04/2007
17	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2024 - 08/2011
12	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2024 - 09/2010
10	Neutropenia 01/2019 - 06/2003
8	Disease Progression 05/2019 - 02/2012
7	Infections 12/2023 - 05/2006
7	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 02/2005
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2021 - 08/2011
5	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 02/2024 - 09/2010
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2018 - 04/2006
3	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2024 - 02/2013
3	Pathologic Complete Response 01/2023 - 12/2014
3	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 08/2014
3	Fatigue 01/2020 - 01/2019
3	Febrile Neutropenia 01/2018 - 06/2015
3	Thrombocytopenia (Thrombopenia) 01/2017 - 03/2016
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2022 - 01/2014
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021 - 07/2021
2	Fever (Fevers) 01/2021 - 01/2017
2	Residual Neoplasm 01/2021 - 11/2020
2	Leukemia 11/2019 - 05/2006
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 08/2017 - 08/2011

Drug/Important Bio-Agent (IBA)

61	Rituximab (Mabthera)FDA Link 02/2024 - 01/2003
20	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 08/2003
19	obinutuzumabIBA 01/2024 - 05/2012
19	Lenalidomide (CC 5013)FDA Link 10/2022 - 09/2013
17	Prednisone (Sone)FDA LinkGeneric 02/2024 - 04/2011
16	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 04/2011
15	Vincristine (Oncovin)FDA LinkGeneric 02/2024 - 04/2007
15	Monoclonal AntibodiesIBA 01/2022 - 01/2003
9	Brentuximab VedotinIBA 02/2024 - 07/2013
7	axicabtagene ciloleucelIBA 05/2024 - 07/2021
7	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2022
7	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2022 - 03/2010
7	Agammaglobulinaemia Tyrosine KinaseIBA 03/2022 - 08/2014
7	ibrutinibIBA 03/2022 - 08/2014
7	ibritumomab tiuxetan (Zevalin)FDA Link 12/2014 - 07/2007
6	romidepsin (FK228)FDA Link 02/2024 - 02/2012
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 02/2017
6	Bendamustine Hydrochloride FDA Link 11/2023 - 11/2013
6	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 04/2011
6	Yttrium-90IBA 12/2014 - 07/2007
5	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2014
5	venetoclaxIBA 11/2021 - 01/2019
5	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 10/2011
4	Vinblastine (Vinblastine Sulfate)FDA Link 11/2023 - 01/2018
4	NivolumabIBA 01/2023 - 01/2017
4	polatuzumab vedotinIBA 01/2022 - 06/2015
3	Chlorambucil (Leukeran)FDA Link 02/2024 - 02/2013
3	pembrolizumabIBA 01/2023 - 11/2019
3	tisagenlecleucelIBA 10/2022 - 07/2021
3	atezolizumabIBA 01/2022 - 01/2021
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2018
3	tazemetostatIBA 01/2022 - 01/2020
3	idelalisibIBA 01/2021 - 01/2017
3	copanlisibIBA 01/2020 - 12/2017
3	Hormones (Hormone)IBA 05/2018 - 02/2010
3	CytokinesIBA 01/2018 - 05/2007
3	pixantrone (BBR 2778)IBA 04/2015 - 08/2003
2	AntibodiesIBA 01/2024 - 10/2011
2	glofitamabIBA 12/2022 - 01/2021
2	PlatinumIBA 03/2022 - 01/2022
2	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 01/2019
2	ruxolitinibIBA 01/2021 - 01/2018
2	EnzymesIBA 01/2021 - 04/2009
2	tirabrutinibIBA 01/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 02/2011
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 12/2014
2	Phosphotransferases (Kinase)IBA 12/2020 - 11/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 11/2018
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2020
2	acalabrutinibIBA 11/2019 - 01/2018
2	abexinostatIBA 01/2017 - 04/2015
2	Antineoplastic Agents (Antineoplastics)IBA 03/2016 - 04/2009
2	coltuximab ravtansineIBA 01/2016 - 01/2014
2	Melphalan (Alkeran)FDA LinkGeneric 12/2014 - 04/2011
2	InterferonsIBA 07/2013 - 12/2008
2	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2010 - 08/2003
2	veltuzumabIBA 05/2010 - 07/2009
1	Glucose (Dextrose)FDA LinkGeneric 04/2024

Therapy/Procedure

56	Therapeutics 05/2024 - 07/2007
37	Drug Therapy (Chemotherapy) 02/2024 - 02/2005
21	Stem Cell Transplantation 05/2024 - 07/2007
7	Immunotherapy 10/2021 - 07/2005
6	Cell Transplantation 01/2018 - 01/2017
6	Radioimmunotherapy 01/2014 - 07/2007
5	Transplantation 11/2019 - 04/2006
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 08/2018 - 12/2017
4	Salvage Therapy 12/2023 - 12/2008
3	Induction Chemotherapy 01/2020 - 05/2006
2	BEAM regimen 12/2014 - 04/2011
2	Intravenous Infusions 01/2014 - 09/2010
2	Autologous Transplantation 07/2013 - 08/2011